BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15195007)

  • 1. Evaluation of the response to therapy of neoplastic lesions.
    Bellomi M; Preda L
    Radiol Med; 2004; 107(5-6):450-8. PubMed ID: 15195007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiologic assessment of response to therapy: comparison of RECIST Versions 1.1 and 1.0.
    Chalian H; Töre HG; Horowitz JM; Salem R; Miller FH; Yaghmai V
    Radiographics; 2011; 31(7):2093-105. PubMed ID: 22084190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual patient data analysis to assess modifications to the RECIST criteria.
    Bogaerts J; Ford R; Sargent D; Schwartz LH; Rubinstein L; Lacombe D; Eisenhauer E; Verweij J; Therasse P;
    Eur J Cancer; 2009 Jan; 45(2):248-60. PubMed ID: 19095437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response evaluation criteria in solid tumours (RECIST): problems and need for modifications in paediatric oncology?
    McHugh K; Kao S
    Br J Radiol; 2003 Jul; 76(907):433-6. PubMed ID: 12857700
    [No Abstract]   [Full Text] [Related]  

  • 5. Response assessment in solid tumours: a comparison of WHO, SWOG and RECIST guidelines.
    Julka PK; Doval DC; Gupta S; Rath GK
    Br J Radiol; 2008 Jun; 81(966):444-9. PubMed ID: 18316345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitations with the response evaluation criteria in solid tumors (RECIST) guidance in disseminated pediatric malignancy.
    Barnacle AM; McHugh K
    Pediatr Blood Cancer; 2006 Feb; 46(2):127-34. PubMed ID: 16231313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiologic measurements of tumor response to treatment: practical approaches and limitations.
    Suzuki C; Jacobsson H; Hatschek T; Torkzad MR; Bodén K; Eriksson-Alm Y; Berg E; Fujii H; Kubo A; Blomqvist L
    Radiographics; 2008; 28(2):329-44. PubMed ID: 18349443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A statistical simulation study finds discordance between WHO criteria and RECIST guideline.
    Mazumdar M; Smith A; Schwartz LH
    J Clin Epidemiol; 2004 Apr; 57(4):358-65. PubMed ID: 15135836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Measurement of tumour response to cancer treatment: morphologic imaging role].
    Ollivier L; Leclère J; Thiesse P; Di Stefano D; Vincent C
    Bull Cancer; 2007 Feb; 94(2):171-7. PubMed ID: 17337386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiological evaluation of tumor response in oncological studies (tumor response evaluation)].
    Gebauer B; Bohnsack O; Riess H
    Rofo; 2011 Aug; 183(8):695-703. PubMed ID: 21391174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New guidelines to evaluate the response to treatment in solid tumors].
    Duffaud F; Therasse P
    Bull Cancer; 2000 Dec; 87(12):881-6. PubMed ID: 11174117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New guidelines to evaluate the response to treatment "RECIST"].
    Sasaki T
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2179-84. PubMed ID: 11142160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A summary report of response evaluation criteria in solid tumors (RECIST criteria)].
    Kusaba H; Saijo N
    Gan To Kagaku Ryoho; 2000 Jan; 27(1):1-5. PubMed ID: 10660728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revised RECIST guideline version 1.1: What oncologists want to know and what radiologists need to know.
    Nishino M; Jagannathan JP; Ramaiya NH; Van den Abbeele AD
    AJR Am J Roentgenol; 2010 Aug; 195(2):281-9. PubMed ID: 20651182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The minimum number of target lesions that need to be measured to be representative of the total number of target lesions (according to RECIST).
    Darkeh MH; Suzuki C; Torkzad MR
    Br J Radiol; 2009 Aug; 82(980):681-6. PubMed ID: 19366735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of tumour response to chemotherapy for metastatic colorectal cancer: accuracy of the RECIST criteria.
    Trillet-Lenoir V; Freyer G; Kaemmerlen P; Fond A; Pellet O; Lombard-Bohas C; Gaudin JL; Lledo G; Mackiewicz R; Gouttebel MC; Moindrot H; Boyer JD; Chassignol L; Stremsdoerfer N; Desseigne F; Moreau JM; Hedelius F; Moraillon A; Chapuis F; Bleuse JP; Barbier Y; Heilmann MO; Valette PJ
    Br J Radiol; 2002 Nov; 75(899):903-8. PubMed ID: 12466256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT of colon cancer metastases to the liver using modified RECIST criteria: determining the ideal number of target lesions to measure.
    Zacharia TT; Saini S; Halpern EF; Sumner JE
    AJR Am J Roentgenol; 2006 Apr; 186(4):1067-70. PubMed ID: 16554580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response criteria in oncologic imaging: review of traditional and new criteria.
    Tirkes T; Hollar MA; Tann M; Kohli MD; Akisik F; Sandrasegaran K
    Radiographics; 2013; 33(5):1323-41. PubMed ID: 24025927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pitfalls in RECIST Data Extraction for Clinical Trials: Beyond the Basics.
    Abramson RG; McGhee CR; Lakomkin N; Arteaga CL
    Acad Radiol; 2015 Jun; 22(6):779-86. PubMed ID: 25794800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activity, objective response, and WHO and RECIST (Response Evaluation Criteria In Solid Tumor) evaluation criteria].
    De Angelis V
    Suppl Tumori; 2004; 3(4):S7-9. PubMed ID: 15206198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.